HealthDay on MSN11h
GLP-1 Receptor Agonist Use Not Linked to Increased Suicide Risk
Glucagon-like peptide-1 (GLP-1) receptor agonists are not associated with an increased risk for suicidality compared with ...
Daily1h
Adding GLP-1 RA to SGLT2i Reduces Mortality and Hospitalization in Heart Failure and ASCVD Patients: Study
Taiwan: A recent cohort study has highlighted the potential benefits of combining glucagon-like peptide-1 receptor agonists ...
News Medical on MSN1d
New study confirms GLP-1 medications are safe for mental health in diabetes
Researchers assess whether GLP-1 receptor agonists increase the risk of suicide, self-harm, or suicidal ideation in type 2 ...
Medpage Today on MSN5d
More Data Assuage Suicide Concerns With GLP-1 Agents
Risk of suicidality wasn't higher for type 2 diabetes patients starting on GLP-1 receptor agonists than for those on two ...
FoodNavigator16h
GLP-1 watch: What’s the latest in weight-loss drugs?
Consumers taking GLP-1 drugs like Ozempic will need to adapt their shopping habits and diets, opening opportunities for food ...
Study finds GLP-1 receptor agonists target fat over muscle for weight loss
Diabetes and obesity have become pressing health issues worldwide. Glucagon-like peptide-1 (GLP-1) receptor agonists, a class ...
Science Daily7d
Genetic evidence that diabetes drug GLP-1 receptor agonists achieve weight loss primarily by reducing fat mass more than muscle
Diabetes and obesity have become pressing health issues worldwide. Glucagon-like peptide-1 (GLP-1) receptor agonists, a class of medications widely used in the treatment of type 2 diabetes (T2D), have ...
MedPage Today8d
GLP-1 Receptor Agonists for Diabetes Tied to Slightly Lower Depression Risk
Opens in a new tab or window Older adults with type 2 diabetes newly treated with a GLP-1 receptor agonist had a lower risk for depression than DPP-4 inhibitor users. There was no difference for ...
Medical Xpress7d
Depression risk lower with GLP-1 receptor agonists versus DPP-4 inhibitors in seniors, study reveals
For older adults with type 2 diabetes (T2D), use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with ...
Medscape4d
GLP-1 Exposure Before and During Pregnancy Linked to Contradictory Outcomes
While one study found lower rates of preterm birth alongside higher rates of hypertensive disorders, another found fewer ...
JD Supra5d
GLP-1 Receptor Agonists: New Frontiers and Challenges
Obesity and diabetes have been two of the greatest public health challenges for decades. Many different diets and fads have promised the public ...
GLP-1 receptor agonists could hold promise for opioid use disorder treatment
Treatment for OUD is currently dominated by opioid agonist therapies that are highly regulated due to their liability for ...